Osteoporotic bone defects pose significant challenges for repair due to the excessive accumulation of reactive oxygen species (ROS) and an imbalance in bone regeneration. In this study, we developed a multifunctional delivery system named OCS-MSN@Res/Mg 2+ , which integrates mesoporous silica nanoparticles (MSN) with a sodium alginate/oxidized carboxymethyl chitosan/silk fibroin composite scaffold (OCS). By forming a complex of Resveratrol (Res) with magnesium ions (Mg 2+ ) and subsequently coating it onto MSN particles, followed by embedding them into the OCS scaffold, the system achieves a coordinated controlled release of antioxidants and osteogenic metabolic promoters. In vitro experiments demonstrated that the system can efficiently scavenge ROS, activate the Nrf2/HO-1 pathway to enhance antioxidant defense mechanisms, regulate macrophage polarization toward an anti-inflammatory phenotype, promote osteogenic differentiation of Osteogenic cells (MC3T3-E1), and stimulate angiogenesis in human umbilical vein endothelial cells (HUVECs). Furthermore, in vivo studies confirmed that this system significantly accelerates femoral defect regeneration in osteoporotic rats. Through its multi-effect synergy involving antioxidation, anti-inflammation, and osteogenesis, this innovative system not only optimizes the bone microenvironment but also enhances regenerative capacity. It provides a promising strategy with significant potential for clinical translation in the precise treatment of osteoporotic bone defects.